BioAtla (BCAB) CFO Waldron gave up 2,371 shares at $0.41 to cover taxes or an exercise price
Insider transactions reported
Richard A Waldron (Chief Financial Officer at BioAtla Inc., BCAB) reported that they gave up 2,371 shares at $0.41 to cover taxes or an exercise price on May 31, 2025. After these transactions the filing shows 340,892 shares held directly.
- Reporting person
- Waldron Richard A
- Role
- Chief Financial Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 31, 2025 | Shares withheld for taxes or exercise price (F) | Common Stock1, 2 | -2,371 | $0.41 | $970 | 340,892 direct |
Holdings before and after
- Common Stock: 343,263 to 340,892 direct
Footnotes from the filing
- 1. This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
- 2. Includes shares purchased under the Issuer's ESPP Plan.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Waldron report in this BCAB Form 4?
Richard A Waldron (Chief Financial Officer at BioAtla Inc., BCAB) reported that they gave up 2,371 shares at $0.41 to cover taxes or an exercise price on May 31, 2025. After these transactions the filing shows 340,892 shares held directly.
How many BCAB shares does Waldron hold after this filing?
The filing shows 340,892 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for BCAB
Earlier insider filings at BCAB
- Jun 3, 2025Officer Vasquez Christian covered exercise/tax liability with 1,566 shares, decreasing direct ownership by 0.55% to 285,130 units (SEC Form 4)
- Mar 13, 2025Officer Vasquez Christian was granted 85,000 shares, increasing direct ownership by 44% to 276,696 units (SEC Form 4)
- Mar 13, 2025Chief Executive Officer Short Jay M Phd was granted 431,000 shares, increasing direct ownership by 24% to 2,256,372 units (SEC Form 4)
- Mar 13, 2025Chief Financial Officer Waldron Richard A was granted 100,000 shares, increasing direct ownership by 43% to 333,263 units (SEC Form 4)
- Mar 13, 2025Chief Medical Officer Sievers Eric was granted 175,000 shares, increasing direct ownership by 90% to 370,032 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2020
Follow BCAB and get a push notification the moment its next story breaks.